查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713624

2025年胚胎着床前基因检测全球市场报告

Preimplantation Genetic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年胚胎着床前基因检测的市场规模将快速成长。到 2029 年，这一数字将成长至 14.1 亿美元，复合年增长率为 11.2%。预测期内的成长归因于不孕症诊所的增加、遗传咨询服务的成长、产妇人口老化、先进基因检测平台的可用性增加以及 PGT 的使用范围扩大。预测期内的主要趋势包括采用先进的定序技术、引入扩展的基因组、开发非侵入性检测方法、胚胎培养系统的进步以及基因编辑技术的进步。

体外受精（IVF）程序数量的增加预计将推动未来胚胎着床前基因检测市场的扩张。在体外受精 (IVF) 中，卵子和精子在体外受精形成胚胎，然后将其植入子宫。试管婴儿数量的增加是由于生殖技术的进步、不孕症的上升以及社会意识的提高。试管婴儿 (IVF) 的激增也导致对胚胎着床前胚胎基因筛检的需求增加，使胚胎着床前基因检测市场受益。例如，美国辅助生殖技术协会于 2024 年 4 月报告称，2022 年有 91,771 名婴儿透过 IVF 出生。因此，IVF 的兴起促进了胚胎着床前基因检测市场的成长。

胚胎着床前基因检测市场的主要企业正在推动次世代定序 (NGS) 技术，以提高基因筛检的准确性、效率和速度。 NGS 工具可对 DNA 和 RNA 进行快速、高通量分析，提供对基因突变和基因表现的详细了解，以增强个人化医疗。例如，美国生技公司赛默飞世尔科技在2023年7月发布了Ion ReproSeq PGT-A Kit和Ion AmpliSeq Polyploidy Kit。这些NGS工具旨在透过使用Ion torrent genexus整合定序仪简化从样本处理到非整倍体分析的工作流程，从而改善IVF和ICSI研究。这项进步将加强胚胎筛检并提高辅助生殖技术的成功率。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球胚胎着床前基因检测市场的 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球胚胎着床前基因检测市场：成长率分析
  • 全球胚胎胚胎着床前基因检测市场表现：规模与成长，2019-2024
  • 全球胚胎胚胎着床前基因检测市场预测：规模与成长，2024-2029，2034
  • 全球胚胎着床前基因检测总目标市场（TAM）

第六章市场区隔

  • 全球胚胎胚胎着床前基因检测市场（依流程、绩效及预测）2019-2024、2024-2029、2034
  • 胚胎胚胎着床前基因筛检
  • 胚胎着床前基因诊断
  • 全球胚胎胚胎着床前基因检测市场（依产品、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 试剂和耗材
  • 装置
  • 软体
  • 全球胚胎胚胎着床前基因检测市场（依技术、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 次世代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 萤光原位杂合反应（FISH）
  • 其他的
  • 全球胚胎胚胎着床前基因检测市场的应用、绩效及预测（2019-2024、2024-2029、2034）
  • 染色体异常
  • 非整倍筛检
  • X连锁疾病
  • 胚胎侦测
  • 人类白血球抗原 (HLA) 分型
  • 其他的
  • 全球胚胎胚胎着床前基因检测市场（依最终用户、绩效及预测）2019-2024、2024-2029、2034
  • 医院
  • 不孕不孕治疗中心
  • 诊断中心
  • 研究中心和学术实验室
  • 全球胚胎胚胎着床前基因检测市场：胚胎着床前基因筛检(PGS) 细分（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 微阵列比较基因组杂合（aCGH）
  • 下一代定序（NGS）
  • 萤光原位杂合反应（FISH）
  • 全球胚胎胚胎着床前基因检测市场：胚胎着床前基因诊断 (PGD) 细分市场（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 单基因疾病检测
  • 染色体异常检测
  • 干细胞移植的HLA型检测

第七章 区域和国家分析

  • 全球胚胎胚胎着床前基因检测市场：依地区、绩效及预测，2019-2024、2024-2029、2034
  • 全球胚胎胚胎着床前基因检测市场（依国家、地区、绩效及预测）2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 胚胎胚胎着床前基因检测市场：竞争格局
  • 胚胎胚胎着床前基因检测市场：公司简介
      • 30.2.1.3 概述、产品和服务、策略和财务分析
    • 30.2.2. By Procedure Overview, Products and Services, Strategy and Financial Analysis
      • 30.2.3.2 概述、产品和服务、策略和财务分析
    • 30.2.4. Preimplantation Genetic Screening Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Preimplantation Genetic Diagnosis Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • By Application
  • Chromosomal Abnormalities
  • Aneuploidy Screening
  • X-Linked Diseases
  • Embryo Testing
  • Human Leukocyte Antigen（HLA）Typing
  • Other Applications
  • By End User
  • Hospitals
  • Fertility Centers
  • Diagnostic Centers
  • Research Centers And Academic Labs
  • Thermo Fisher Scientific

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年胚胎胚胎着床前基因检测市场：哪些国家将带来新机会
  • 2029年胚胎胚胎着床前基因检测市场：细分领域带来新机会
  • 2029年胚胎胚胎着床前基因检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33526

Preimplantation genetic testing (PGT) is a procedure used to examine embryos for genetic abnormalities before they are implanted during in vitro fertilization (IVF). This testing aims to identify genetic issues to prevent certain inherited conditions, thus improving the chances of a successful pregnancy. PGT helps increase the likelihood of successful implantation, reduces the risk of miscarriage, and prevents genetic diseases.

The main types of preimplantation genetic testing are preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD). PGS involves analyzing embryos for chromosomal abnormalities before implantation. Products used in PGT include reagents and consumables, instruments, and software, and various technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), and fluorescent in situ hybridization (FISH). These procedures are employed for applications including chromosomal abnormalities, aneuploidy screening, X-linked diseases, embryo testing, and human leukocyte antigen (HLA) typing. The testing is utilized by various end users, including hospitals, fertility centers, diagnostic centers, research institutions, and academic laboratories.

The preimplantation genetic testing market research report is one of a series of new reports from The Business Research Company that provides preimplantation genetic testing market statistics, including preimplantation genetic testing industry global market size, regional shares, competitors with a preimplantation genetic testing market share, detailed preimplantation genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the preimplantation genetic testing industry. This preimplantation genetic testing market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The preimplantation genetic testing market size has grown rapidly in recent years. It will grow from $0.83 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing incidence of genetic disorders, growing awareness of genetic testing, increase in prenatal testing options, growing demand for personalized medicine, and increasing focus on preventive healthcare.

The preimplantation genetic testing market size is expected to see rapid growth in the next few years. It will grow to $1.41 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to the rising number of fertility clinics, growth in genetic counseling services, growing prevalence of advanced maternal age, increasing availability of advanced genetic testing platforms, and expanding applications of PGT. Major trends in the forecast period include the adoption of advanced sequencing technologies, implementation of expanded genetic panels, development of non-invasive testing methods, advancements in embryo culture systems, and advancements in genetic editing technologies.

The growing number of in vitro fertilization (IVF) procedures is projected to drive the expansion of the preimplantation genetic testing market in the future. IVF involves fertilizing an egg with sperm outside the body to create an embryo, which is then implanted into the uterus. The increase in IVF procedures is fueled by advancements in reproductive technology, rising infertility rates, and greater public awareness. This surge in IVF practices is also leading to a higher demand for genetic screening of embryos before implantation, thereby benefiting the preimplantation genetic testing market. For example, the Society for Assisted Reproductive Technology, a U.S.-based organization, reported in April 2024 that 91,771 babies were born through IVF in 2022. Consequently, the rise in IVF procedures is contributing to the growth of the preimplantation genetic testing market.

Key players in the preimplantation genetic testing market are advancing next-generation sequencing (NGS) technologies to improve the accuracy, efficiency, and speed of genetic screening. NGS tools provide rapid, high-throughput analysis of DNA and RNA, offering detailed insights into genetic variations and gene expression, which enhances personalized medicine. For instance, in July 2023, Thermo Fisher Scientific, a US-based biotechnology firm, introduced the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These NGS tools are designed to improve IVF and ICSI research by streamlining workflows from sample processing to aneuploidy analysis using the ion torrent genexus integrated sequencer. This advancement enhances embryo screening and boosts success rates in assisted reproductive technologies.

In June 2022, Kindbody, a U.S.-based provider of fertility and wellness services, acquired the genomics company Phosphorus Labs for an undisclosed amount. This acquisition enables Kindbody to incorporate genetic testing capabilities into its fertility services, thereby improving patient care with personalized treatment plans. Phosphorus Labs specializes in preimplantation genetic testing in the U.S.

Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Progyny Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd, Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC

North America was the largest region in the preimplantation genetic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the preimplantation genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The preimplantation genetic testing (PGT) market consists of revenues earned by entities by providing services such as data analysis tools, genetic counseling, cloud-based platforms, and embryo selection algorithms. The market value includes the value of related goods sold by the service provider or included within the service offering. The preimplantation genetic testing (PGT) market also includes sales of genetic testing (PGT) kits, next-generation sequencers, and polymerase chain reaction (PCR) machines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Preimplantation Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on preimplantation genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for preimplantation genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The preimplantation genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Procedure: Preimplantation Genetic Screening; Preimplantation Genetic Diagnosis
  • 2) By Product: Reagents And Consumables; Instruments; Software
  • 3) By Technology: Next Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Fluorescent In Situ Hybridization (FISH); Other Technologies
  • 4) By Application: Chromosomal Abnormalities; Aneuploidy Screening; X-Linked Diseases; Embryo Testing; Human Leukocyte Antigen (HLA) Typing; Other Applications
  • 5) By End User: Hospitals; Fertility Centers; Diagnostic Centers; Research Centers And Academic Labs
  • Subsegments:
  • 1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH); Next-Generation Sequencing (NGS); Fluorescence In Situ Hybridization (FISH)
  • 2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing; Chromosomal Abnormalities Testing; HLA Typing for Stem Cell Transplantation
  • Companies Mentioned: Thermo Fisher Scientific; Abbott Laboratories; Laboratory Corporation of America Holdings; Agilent Technologies Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Preimplantation Genetic Testing Market Characteristics

3. Preimplantation Genetic Testing Market Trends And Strategies

4. Preimplantation Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Preimplantation Genetic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Preimplantation Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Preimplantation Genetic Testing Market Growth Rate Analysis
  • 5.4. Global Preimplantation Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Preimplantation Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Preimplantation Genetic Testing Total Addressable Market (TAM)

6. Preimplantation Genetic Testing Market Segmentation

  • 6.1. Global Preimplantation Genetic Testing Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Preimplantation Genetic Screening
  • Preimplantation Genetic Diagnosis
  • 6.2. Global Preimplantation Genetic Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Consumables
  • Instruments
  • Software
  • 6.3. Global Preimplantation Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescent In Situ Hybridization (FISH)
  • Other Technologies
  • 6.4. Global Preimplantation Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chromosomal Abnormalities
  • Aneuploidy Screening
  • X-Linked Diseases
  • Embryo Testing
  • Human Leukocyte Antigen (HLA) Typing
  • Other Applications
  • 6.5. Global Preimplantation Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Fertility Centers
  • Diagnostic Centers
  • Research Centers And Academic Labs
  • 6.6. Global Preimplantation Genetic Testing Market, Sub-Segmentation Of Preimplantation Genetic Screening (PGS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Array Comparative Genomic Hybridization (aCGH)
  • Next-Generation Sequencing (NGS)
  • Fluorescence In Situ Hybridization (FISH)
  • 6.7. Global Preimplantation Genetic Testing Market, Sub-Segmentation Of Preimplantation Genetic Diagnosis (PGD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monogenic Disorders Testing
  • Chromosomal Abnormalities Testing
  • HLA Typing for Stem Cell Transplantation

7. Preimplantation Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Preimplantation Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Preimplantation Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Preimplantation Genetic Testing Market

  • 8.1. Asia-Pacific Preimplantation Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

9. China Preimplantation Genetic Testing Market

  • 9.1. China Preimplantation Genetic Testing Market Overview

10. India Preimplantation Genetic Testing Market

11. Japan Preimplantation Genetic Testing Market

  • 11.1. Japan Preimplantation Genetic Testing Market Overview

12. Australia Preimplantation Genetic Testing Market

13. Indonesia Preimplantation Genetic Testing Market

14. South Korea Preimplantation Genetic Testing Market

  • 14.1. South Korea Preimplantation Genetic Testing Market Overview

15. Western Europe Preimplantation Genetic Testing Market

  • 15.1. Western Europe Preimplantation Genetic Testing Market Overview

16. UK Preimplantation Genetic Testing Market

17. Germany Preimplantation Genetic Testing Market

18. France Preimplantation Genetic Testing Market

19. Italy Preimplantation Genetic Testing Market

20. Spain Preimplantation Genetic Testing Market

21. Eastern Europe Preimplantation Genetic Testing Market

  • 21.1. Eastern Europe Preimplantation Genetic Testing Market Overview

22. Russia Preimplantation Genetic Testing Market

23. North America Preimplantation Genetic Testing Market

  • 23.1. North America Preimplantation Genetic Testing Market Overview

24. USA Preimplantation Genetic Testing Market

  • 24.1. USA Preimplantation Genetic Testing Market Overview

25. Canada Preimplantation Genetic Testing Market

  • 25.1. Canada Preimplantation Genetic Testing Market Overview

26. South America Preimplantation Genetic Testing Market

  • 26.1. South America Preimplantation Genetic Testing Market Overview

27. Brazil Preimplantation Genetic Testing Market

28. Middle East Preimplantation Genetic Testing Market

  • 28.1. Middle East Preimplantation Genetic Testing Market Overview

29. Africa Preimplantation Genetic Testing Market

  • 29.1. Africa Preimplantation Genetic Testing Market Overview

30. Preimplantation Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Preimplantation Genetic Testing Market Competitive Landscape
  • 30.2. Preimplantation Genetic Testing Market Company Profiles
      • 30.2.1.3 Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. By Procedure Overview, Products and Services, Strategy and Financial Analysis
      • 30.2.3.2 Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Preimplantation Genetic Screening Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Preimplantation Genetic Diagnosis Overview, Products and Services, Strategy and Financial Analysis

31. Preimplantation Genetic Testing Market Other Major And Innovative Companies

  • 31.1. By Application
  • 31.2.6
  • 31.3. Chromosomal Abnormalities
  • 31.4. Aneuploidy Screening
  • 31.5. X-Linked Diseases
  • 31.6. Embryo Testing
  • 31.7. Human Leukocyte Antigen (HLA) Typing
  • 31.8. Other Applications
  • 31.9. By End User
  • 31.10.4
  • 31.11. Hospitals
  • 31.12. Fertility Centers
  • 31.13. Diagnostic Centers
  • 31.14. Research Centers And Academic Labs
  • 31.15. Thermo Fisher Scientific

32. Global Preimplantation Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Preimplantation Genetic Testing Market

34. Recent Developments In The Preimplantation Genetic Testing Market

35. Preimplantation Genetic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Preimplantation Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Preimplantation Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Preimplantation Genetic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33526_Preimplantation_Genetic_Testing_GMR_2025